228 related articles for article (PubMed ID: 26961996)
1. Plasma Anti-Müllerian Hormone Concentrations and Risk of Breast Cancer among Premenopausal Women in the Nurses' Health Studies.
Eliassen AH; Zeleniuch-Jacquotte A; Rosner B; Hankinson SE
Cancer Epidemiol Biomarkers Prev; 2016 May; 25(5):854-60. PubMed ID: 26961996
[TBL] [Abstract][Full Text] [Related]
2. Anti-Müllerian hormone levels and incidence of early natural menopause in a prospective study.
Bertone-Johnson ER; Manson JE; Purdue-Smithe AC; Steiner AZ; Eliassen AH; Hankinson SE; Rosner BA; Whitcomb BW
Hum Reprod; 2018 Jun; 33(6):1175-1182. PubMed ID: 29659835
[TBL] [Abstract][Full Text] [Related]
3. Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women.
Eliassen AH; Missmer SA; Tworoger SS; Spiegelman D; Barbieri RL; Dowsett M; Hankinson SE
J Natl Cancer Inst; 2006 Oct; 98(19):1406-15. PubMed ID: 17018787
[TBL] [Abstract][Full Text] [Related]
4. Premenopausal endogenous steroid hormones and breast cancer risk: results from the Nurses' Health Study II.
Fortner RT; Eliassen AH; Spiegelman D; Willett WC; Barbieri RL; Hankinson SE
Breast Cancer Res; 2013 Mar; 15(2):R19. PubMed ID: 23497468
[TBL] [Abstract][Full Text] [Related]
5. Anti-Müllerian hormone concentrations in premenopausal women and breast cancer risk.
Nichols HB; Baird DD; Stanczyk FZ; Steiner AZ; Troester MA; Whitworth KW; Sandler DP
Cancer Prev Res (Phila); 2015 Jun; 8(6):528-34. PubMed ID: 25873369
[TBL] [Abstract][Full Text] [Related]
6. Circulating levels of insulin-like growth factors, their binding proteins, and breast cancer risk.
Schernhammer ES; Holly JM; Pollak MN; Hankinson SE
Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):699-704. PubMed ID: 15767352
[TBL] [Abstract][Full Text] [Related]
7. Breast Cancer Risk Factors and Circulating Anti-Müllerian Hormone Concentration in Healthy Premenopausal Women.
Clendenen TV; Ge W; Koenig KL; Afanasyeva Y; Agnoli C; Bertone-Johnson E; Brinton LA; Darvishian F; Dorgan JF; Eliassen AH; Falk RT; Hallmans G; Hankinson SE; Hoffman-Bolton J; Key TJ; Krogh V; Nichols HB; Sandler DP; Schoemaker MJ; Sluss PM; Sund M; Swerdlow AJ; Visvanathan K; Liu M; Zeleniuch-Jacquotte A
J Clin Endocrinol Metab; 2021 Oct; 106(11):e4542-e4553. PubMed ID: 34157104
[TBL] [Abstract][Full Text] [Related]
8. A prospective study of plasma prolactin concentrations and risk of premenopausal and postmenopausal breast cancer.
Tworoger SS; Eliassen AH; Sluss P; Hankinson SE
J Clin Oncol; 2007 Apr; 25(12):1482-8. PubMed ID: 17372279
[TBL] [Abstract][Full Text] [Related]
9. Insulin-like growth factor-I, its binding proteins (IGFBP-1 and IGFBP-3), and growth hormone and breast cancer risk in The Nurses Health Study II.
Schernhammer ES; Holly JM; Hunter DJ; Pollak MN; Hankinson SE
Endocr Relat Cancer; 2006 Jun; 13(2):583-92. PubMed ID: 16728584
[TBL] [Abstract][Full Text] [Related]
10. Circulating anti-Müllerian hormone and breast cancer risk: A study in ten prospective cohorts.
Ge W; Clendenen TV; Afanasyeva Y; Koenig KL; Agnoli C; Brinton LA; Dorgan JF; Eliassen AH; Falk RT; Hallmans G; Hankinson SE; Hoffman-Bolton J; Key TJ; Krogh V; Nichols HB; Sandler DP; Schoemaker MJ; Sluss PM; Sund M; Swerdlow AJ; Visvanathan K; Liu M; Zeleniuch-Jacquotte A
Int J Cancer; 2018 Jun; 142(11):2215-2226. PubMed ID: 29315564
[TBL] [Abstract][Full Text] [Related]
11. Association between plasma prolactin concentrations and risk of breast cancer among predominately premenopausal women.
Tworoger SS; Sluss P; Hankinson SE
Cancer Res; 2006 Feb; 66(4):2476-82. PubMed ID: 16489055
[TBL] [Abstract][Full Text] [Related]
12. The association of plasma DHEA and DHEA sulfate with breast cancer risk in predominantly premenopausal women.
Tworoger SS; Missmer SA; Eliassen AH; Spiegelman D; Folkerd E; Dowsett M; Barbieri RL; Hankinson SE
Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):967-71. PubMed ID: 16702378
[TBL] [Abstract][Full Text] [Related]
13. Serum sex steroids in premenopausal women and breast cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC).
Kaaks R; Berrino F; Key T; Rinaldi S; Dossus L; Biessy C; Secreto G; Amiano P; Bingham S; Boeing H; Bueno de Mesquita HB; Chang-Claude J; Clavel-Chapelon F; Fournier A; van Gils CH; Gonzalez CA; Gurrea AB; Critselis E; Khaw KT; Krogh V; Lahmann PH; Nagel G; Olsen A; Onland-Moret NC; Overvad K; Palli D; Panico S; Peeters P; Quirós JR; Roddam A; Thiebaut A; Tjønneland A; Chirlaque MD; Trichopoulou A; Trichopoulos D; Tumino R; Vineis P; Norat T; Ferrari P; Slimani N; Riboli E
J Natl Cancer Inst; 2005 May; 97(10):755-65. PubMed ID: 15900045
[TBL] [Abstract][Full Text] [Related]
14. Premenopausal plasma ferritin levels, HFE polymorphisms, and risk of breast cancer in the nurses' health study II.
Graff RE; Cho E; Lindström S; Kraft P; Willett WC; Eliassen AH
Cancer Epidemiol Biomarkers Prev; 2014 Mar; 23(3):516-24. PubMed ID: 24443403
[TBL] [Abstract][Full Text] [Related]
15. Premenopausal plasma carotenoids, fluorescent oxidation products, and subsequent breast cancer risk in the nurses' health studies.
Sisti JS; Lindström S; Kraft P; Tamimi RM; Rosner BA; Wu T; Willett WC; Eliassen AH
Breast Cancer Res Treat; 2015 Jun; 151(2):415-25. PubMed ID: 25917867
[TBL] [Abstract][Full Text] [Related]
16. Plasma sex hormone concentrations and subsequent risk of breast cancer among women using postmenopausal hormones.
Tworoger SS; Missmer SA; Barbieri RL; Willett WC; Colditz GA; Hankinson SE
J Natl Cancer Inst; 2005 Apr; 97(8):595-602. PubMed ID: 15840882
[TBL] [Abstract][Full Text] [Related]
17. Anti-Mullerian hormone and risk of invasive serous ovarian cancer.
Schock H; Lundin E; Vääräsmäki M; Grankvist K; Fry A; Dorgan JF; Pukkala E; Lehtinen M; Surcel HM; Lukanova A
Cancer Causes Control; 2014 May; 25(5):583-9. PubMed ID: 24562905
[TBL] [Abstract][Full Text] [Related]
18. Circulating concentrations of insulin-like growth factor-I and risk of breast cancer.
Hankinson SE; Willett WC; Colditz GA; Hunter DJ; Michaud DS; Deroo B; Rosner B; Speizer FE; Pollak M
Lancet; 1998 May; 351(9113):1393-6. PubMed ID: 9593409
[TBL] [Abstract][Full Text] [Related]
19. Pretreatment anti-Mullerian hormone-based nomogram predicts menstruation status after chemotherapy for premenopausal women with hormone receptor-positive early breast cancer.
Xue C; Wei W; Sun P; Zheng W; Diao X; Xu F; Huang J; An X; Xia W; Hong R; Jiang K; Huang R; Yuan Z; Wang S; Li A; Zou R; Shi Y
Breast Cancer Res Treat; 2019 Feb; 173(3):619-628. PubMed ID: 30392113
[TBL] [Abstract][Full Text] [Related]
20. Plasma adiponectin concentrations and risk of incident breast cancer.
Tworoger SS; Eliassen AH; Kelesidis T; Colditz GA; Willett WC; Mantzoros CS; Hankinson SE
J Clin Endocrinol Metab; 2007 Apr; 92(4):1510-6. PubMed ID: 17213279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]